Wishful thinking but ...........On the whole, the analysts don't seem too alarmed. They lowered their target price expectations because of FDA delays but are generally still upbeat. Pierre was evasive on the conference call yesterday as to FDA progress etc. etc. Perhaps Pierre & Compnay have a much closer feel of where we stand with the FDA. This 'in limbo' feel that we have been given may be a good thing. The best way to attack the shorts or whatever is driving our share price down is the element of surprise. To have some meaningfull announcement soon would be a great way for Pierre to stick it to 'the shorts and others' that are doing this to Prometic.